Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
21 nov. 2024 08h00 HE
|
Upstream Bio
Upstream Bio CEO to participate in fireside chat at Piper Sandler
COPD and Asthma Devices Market Projected to Reach $44.95 Billion in 2024 with Continued Expansion through 2028, Driven by Technological Innovations and Rising Prevalence - Forecasts to 2033
07 nov. 2024 09h23 HE
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering. ...
Acute Respiratory Distress Syndrome Research Report 2024: Market to Grow at a CAGR of 8.7% During 2025-2030, Driven by Technological Advances in Diagnostics and Therapies
23 oct. 2024 06h28 HE
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration,...
Intelligent Asthma Monitoring Devices Market Research 2024: Partnerships Between Pharma and Smart Inhaler Firms to Revolutionize Asthma Management - Global Long-term Forecasts to 2028 and 2033
17 oct. 2024 04h01 HE
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Intelligent Asthma Monitoring Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The intelligent asthma monitoring...
Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Pfizer, GSK, Novartis, Astellas, Abbott, Boehringer Ingelheim, Almirall
10 sept. 2024 05h12 HE
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis,...
United States Pulmonary/Respiratory Diseases KOLs Fair-Market Value Compensation Rates Report: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)
10 juil. 2024 05h29 HE
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The " Fair-Market Value Compensation Rates for Pulmonary/Respiratory Diseases KOLs - United States" report has been added to ResearchAndMarkets.com's...
Emerging Respiratory Care Companies, 2024: Strategic Profiles and Growth Opportunities to 2028
26 juin 2024 06h50 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Emerging Respiratory Care Companies: Strategic Profiles and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.This...
Global Cystic Fibrosis Market Report 2024: Growth Amid Rising Prevalence and Innovative Therapeutic Developments - Forecasts to 2029
21 juin 2024 06h58 HE
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. Emerging Therapeutics and...
Global Cystic Fibrosis Market Analysis & Forecasts 2024-2034: Focus on Mucolytics, Bronchodilators, Cystic Fibrosis Transmembrane Conductance Regulator Modulators, & Pancreatic Enzyme Supplements
13 juin 2024 10h08 HE
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global cystic...
Global Cystic Fibrosis Market Analysis & 10 Year Forecast 2024-2034: By Drug Class, CFTR Modulators was the Highest Revenue-Grossing Segment in the Global Cystic Fibrosis Market in 2023
09 avr. 2024 04h13 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global cystic...